Second Phase-III-Induction Study (U-ACCOMPLISH) of Upadacitinib confirms improved clinical, endoscopic and histological Results in Patients with Ulcerative colitis

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2021年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Pangan, Aileen
    Greenbloom, Susan
    D'Haens, Geert
    Panes, Julian
    Juillerat, Pascal
    Lindsay, James
    Loftus, Edward V.
    Sandborn, William
    Reinisch, Walter
    Sanchez-Gonzalez, Yuri
    Huang, Bidan
    Xian, Wangang
    Liu, Jianzhong
    Weinreich, Michael
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S357 - S357
  • [2] Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
    Vermeire, S.
    Danese, S.
    Zhou, W.
    Pangan, A.
    Greenbloom, S.
    D'Haens, G.
    Panes, J.
    Juillerat, P.
    Lindsay, J. O.
    Loftus, E. V., Jr.
    Sandborn, W. J.
    Reinisch, W.
    Gonzalez, Y. Sanchez
    Huang, B.
    Xie, W.
    Liu, J.
    Weinreich, M. A.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S021 - S022
  • [3] The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
    D'Haens, G.
    Tran, J.
    Danese, S.
    Rubin, D. T.
    Aoyama, N.
    Lugering, A.
    Klaff, J.
    Xuan, S.
    Ilo, D.
    Gonzalez, Y. Sanchez
    Panes, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I27 - I29
  • [4] Effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
    Pudipeddi, A.
    D'Haens, G.
    Tran, J.
    Danese, S.
    Rubin, D. T.
    Aoyama, N.
    Luegering, A.
    Klaff, J.
    Xuan, S.
    Ilo, D.
    Gonzalez, Y. Sanchez
    Panes, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 137 - 138
  • [5] THE EFFECTS OF UPADACITINIB ON ULCERATIVE COLITIS SYMPTOM RESOLUTION AND FATIGUE NORMALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U-ACHIEVE AND U-ACCOMPLISH RESULTS
    D'Haens, Geert
    Tran, Jacinda N.
    Danese, Silvio
    Rubin, David T.
    Aoyama, Nobuo
    Lugering, Andreas
    Klaff, Justin
    Xuan, Si
    Ilo, Dapo
    Gonzalez, Yuri Sanchez
    Panes, Julian
    GASTROENTEROLOGY, 2023, 164 (06) : S1102 - S1103
  • [6] Upadacitinib promotes histological and endoscopic mucosal healing: Results from the Upadacitinib Ulcerative Colitis Phase 3 program
    Peyrin-Biroulet, L.
    Siegel, C. A.
    Tanida, S.
    Torres, E.
    Bossuyt, P.
    Dubinsky, M. C.
    Baert, F.
    Zhou, W.
    Klaff, J.
    Berg, S.
    Laroux, F. S.
    Gonzalez, Y. S.
    Yao, X.
    Zhou, Q.
    Reinisch, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 166 - 168
  • [7] Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study
    Dalal, Rahul S.
    Kallumkal, Govind
    Cabral, Heidy J.
    Bachour, Salam
    Barnes, Edward L.
    Allegretti, Jessica R.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (07) : 1207 - 1210
  • [8] Results from the UPITA-Colitis Registry on the Effectiveness and Safety of Upadacitinib in the Induction phase in Patients with Ulcerative Colitis
    Caballero Mateos, A. M.
    Gonzalez-Parra, A. C.
    Gutierrez-Holanda, C.
    Trapero-Martinez, A. M.
    Hernandez-Martinez, A.
    Rojas-Feria, M.
    Martin-Rodriguez, M. D. M.
    Rodriguez-Gonzalez, F. J.
    Saldana, L.
    Benitez, J. M.
    Gomez-Delgado, E.
    Miras, L.
    Gonzalez, J.
    Mata, F. J.
    Olmedo-Martin, R., V
    GATE, II
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2042 - i2044
  • [9] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
    Danese, S.
    Vermeire, S.
    Zhou, W.
    Pangan, A.
    Siffledeen, J.
    Hebuterne, X.
    Nakase, H.
    Higgins, P.
    Chen, M. H.
    Sanchez-Gonzalez, Y.
    Huang, B.
    Xie, W.
    Liu, J.
    Weinreich, M.
    Pannaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024
  • [10] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study
    Danese, Silvio
    Vermeire, Severine
    Zhou, Wen
    Pangan, Aileen
    Siffledeen, Jesse
    Hebuterne, Xavier
    Nakase, Hiroshi
    Chen, Minhu
    Higgins, Peter
    Sanchez-Gonzalez, Yuri
    Huang, Bidan
    Xian, Wangang
    Liu, Jianzhong
    Weinreich, Michael
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313
12345